XBIO 8-K 2026-09-23

Xenetic Biosciences, Inc. (XBIO) 8-K dated 2026-09-23 — accession 0001683168-26-007340. This URL is the filing, not the XBIO hub.

Xenetic Biosciences, Inc. (XBIO) is a biotechnology company listed on US.

Xenetic Biosciences, Inc. filed a 8-K on 2026-09-23. Accession 0001683168-26-007340.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported XBIO revenue for 2025-12-31 was $3.0M. Net income was -$2.7M. Revenue was up 19.0% from 2024-12-31 to 2025-12-31. XBIO currently screens at market cap $5.7M.

Not investment advice. The XBIO SEC hub lists recent forms. The stock page is the research view.